15 Hrs
Source:
برلمان.كوم
_1777011671128_85597701.png&w=48&q=75){kind=small}
Researchers develop cancer resistance therapy
Researchers in the United States have developed an experimental drug compound called CS18, which shows promising potential in fighting cancer by disrupting the mechanisms that cancer cells rely on to survive and resist current treatments. Laboratory studies have demonstrated that this compound effectively diminishes the tumor's ability to resist drugs, thereby increasing the prospects for developing more effective therapies in the future.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)